Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cytometry B Clin Cytom. 2014 Oct 23;88(1):6–20. doi: 10.1002/cyto.b.21196

Table 1.

PE-Conjugated Dextramer and Tetramer Reagents Employed in the Study

Dextramers iTAg™ MHC Tetramers Antigen
HLA-A*01 (VTEHDTLLY) HLA-A*01 (VTEHDTLLY) pp50
HLA-A*02 (NLVPMVATV) HLA-A*02 (NLVPMVATV) pp65
HLA-A*03 (KLGGALQAK) IE-1
HLA-A*24 (QYDPVAALF) HLA-A*24 (QYDPVAALF) pp65
HLA-B*07 (RPHERNGFTVL) pp65
HLA-B*07 (TPRVTGGGAM) HLA-B*07 (TPRVTGGGAM) pp65
HLA-B*08 (ELRRKMMYM) HLA-B*08 (ELRRKMMYM) pp65
HLA-B*35 (IPSINVHHY) HLA-B*35 (IPSINVHHY) pp65
Negative Control 1 (Irrelevant Control Peptide) Negative Control (Unspecified Haplotype and Peptide) N / A*
Negative Control 2 (Irrelevant Control Peptide) N / A*
*

N/A=Not Applicable. For Dextramer reagents, nonsense peptides are used. For Tetramer reagents, this information is not available.